Global Prevalence of Chlamydial Infections in Reptiles: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 21 (1) ◽  
pp. 32-39
Author(s):  
Rawikan Inchuai ◽  
Sompoth Weerakun ◽  
Hoai Nam Nguyen ◽  
Peerapol Sukon
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Global Prevalence ◽  
Chlamydial Infections

scholarly journals The global prevalence of apical periodontitis: a systematic review and meta‐analysis

2020 ◽  
Author(s):  
C.S. Tibúrcio‐Machado ◽  
C. Michelon ◽  
F.B. Zanatta ◽  
M.S. Gomes ◽  
J.A. Marin ◽  
...  
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Apical Periodontitis ◽  
Global Prevalence

The Global Prevalence of Peptic Ulcer in the World: a Systematic Review and Meta-analysis

2021 ◽  
Author(s):  
Nader Salari ◽  
Niloofar Darvishi ◽  
Shamarina Shohaimi ◽  
Yalda Bartina ◽  
Melika Ahmadipanah ◽  
...  
Keyword(s):  
Systematic Review ◽  
Peptic Ulcer ◽  
Meta Analysis ◽  
Global Prevalence ◽  
The World

Global prevalence of dental caries in athletes with intellectual disabilities: An epidemiological systematic review and meta-analysis

2018 ◽  
Vol 39 (2) ◽  
pp. 114-124 ◽  
Author(s):  
Fellipe Navarro Azevedo de Azeredo ◽  
Ludmila Silva Guimarães ◽  
Lívia Azeredo A. Antunes ◽  
Leonardo Santos Antunes
Keyword(s):  
Systematic Review ◽  
Dental Caries ◽  
Intellectual Disabilities ◽  
Meta Analysis ◽  
Global Prevalence

Global prevalence of burnout symptoms among nurses: A systematic review and meta-analysis

2020 ◽  
Vol 123 ◽  
pp. 9-20 ◽  
Author(s):  
Tiffany Woo ◽  
Roger Ho ◽  
Arthur Tang ◽  
Wilson Tam
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Global Prevalence

scholarly journals The global prevalence of latent tuberculosis: a systematic review and meta-analysis

2019 ◽  
Vol 54 (3) ◽  
pp. 1900655 ◽  
Author(s):  
Adam Cohen ◽  
Victor Dahl Mathiasen ◽  
Thomas Schön ◽  
Christian Wejse
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Latent Tuberculosis ◽  
Interferon Γ ◽  
Preventive Therapy ◽  
Incidence Rates ◽  
World Health ◽  
Global Prevalence ◽  
Ltbi Prevalence ◽  
Health Organization

In 1999, the World Health Organization (WHO) estimated that one-third of the world's population had latent tuberculosis infection (LTBI), which was recently updated to one-fourth. However, this is still based on controversial assumptions in combination with tuberculin skin test (TST) surveys. Interferon-γ release assays (IGRAs) with a higher specificity than TST have since been widely implemented, but never used to estimate the global LTBI prevalence.We conducted a systematic review and meta-analysis of LTBI estimates based on both IGRA and TST results published between 2005 and 2018. Regional and global estimates of LTBI prevalence were calculated. Stratification was performed for low, intermediate and high TB incidence countries and a pooled estimate for each area was calculated using a random effects model.Among 3280 studies screened, we included 88 studies from 36 countries with 41 IGRA (n=67 167) and 67 TST estimates (n=284 644). The global prevalence of LTBI was 24.8% (95% CI 19.7–30.0%) and 21.2% (95% CI 17.9–24.4%), based on IGRA and a 10-mm TST cut-off, respectively. The prevalence estimates correlated well to WHO incidence rates (Rs=0.70, p<0.001).In the first study of the global prevalence of LTBI derived from both IGRA and TST surveys, we found that one-fourth of the world's population is infected. This is of relevance, as both tests, although imperfect, are used to identify individuals eligible for preventive therapy. Enhanced efforts are needed targeting the large pool of latently infected individuals, as this constitutes an enormous source of potential active tuberculosis.

scholarly journals Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling

2018 ◽  
Vol 102 (7) ◽  
pp. 855-862 ◽  
Author(s):  
Timothy R Fricke ◽  
Monica Jong ◽  
Kovin S Naidoo ◽  
Padmaja Sankaridurg ◽  
Thomas J Naduvilath ◽  
...  
Keyword(s):  
Systematic Review ◽  
Visual Impairment ◽  
Macular Degeneration ◽  
Meta Analysis ◽  
Temporal Trends ◽  
Prevalence Data ◽  
Specific Data ◽  
Relative Age ◽  
Global Prevalence ◽  
Age Dependent

PurposeWe used systematic review and meta-analysis to identify and assimilate evidence quantifying blindness and visual impairment (VI) associated with myopic macular degeneration (MMD), then derived models to predict global patterns. The models were used to estimate the global prevalence of blindness and VI associated with MMD from 2000 to 2050.MethodsThe systematic review identified 17 papers with prevalence data for MMD VI fitting our inclusion criteria. Data from six papers with age-specific data were scaled to relative age-dependent risk and meta-analysed at VI and blindness levels. We analysed variance in all MMD VI and blindness data as a proportion of high myopia against variables from the place and year of data collection, with a model based on health expenditure providing the best correlation. We used this model to estimate the prevalence and number of people with MMD VI in each country in each decade.ResultsWe included data from 17 studies comprising 137 514 participants. We estimated 10.0 million people had VI from MMD in 2015 (prevalence 0.13%, 95% CI 5.5 to 23.7 million, 0.07% to 0.34%), 3.3 million of whom were blind (0.04%, 1.8 to 7.8 million, 0.03% to 0.10%). We estimate that by 2050, without changing current interventions, VI from MMD will grow to 55.7 million people (0.57%, 29.0 to 119.7 million, 0.33% to 1.11%), 18.5 million of whom will be blind (0.19%, 9.6 to 39.7 million, 0.11% to 0.37%).ConclusionThe burden of MMD blindness and VI will rise significantly without efforts to reduce the development and progression of myopia and improve the management of MMD.

Sign in / Sign up

Export Citation Format

Share Document